NeoGenomics, Inc. Accrued Liabilities, Current
NeoGenomics, Inc. (NEO) had Accrued Liabilities, Current of $1.21 million as of 2014-12-31, per its 10-K filed 2015-03-03.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2015-03-03
- 2014-12-31: Accrued Liabilities, Current $1.21M.
- 2014-09-30: Accrued Liabilities, Current $1.10M.
- 2014-06-30: Accrued Liabilities, Current $651.00K.
- 2014-03-31: Accrued Liabilities, Current $461.00K.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2014-12-31 | $1.21M 10-K · filed 2015-03-03 |
| 2014-09-30 | $1.10M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $651.00K 10-Q · filed 2014-07-29 |
| 2014-03-31 | $461.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $741.00K 10-K · filed 2015-03-03 |
| 2013-09-30 | $755.00K 10-Q · filed 2013-10-30 |
| 2013-06-30 | $631.00K 10-Q · filed 2013-08-02 |
| 2013-03-31 | $662.00K 10-Q · filed 2013-05-13 |
| 2012-12-31 | $669.00K 10-K · filed 2014-02-24 |
| 2012-09-30 | $690.00K 10-Q · filed 2012-11-05 |
| 2012-06-30 | $691.00K 10-Q/A · filed 2012-08-15 |
| 2012-03-31 | $818.00K 10-Q · filed 2012-05-14 |
| 2011-12-31 | $773.00K 10-K · filed 2013-02-21 |
| 2011-09-30 | $625.00K 10-Q · filed 2011-10-25 |
| 2011-06-30 | $573.00K 10-Q/A · filed 2011-08-01 |
| 2010-12-31 | $460.00K 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |